OPR - Delayed Quote • USD FOLD Oct 2024 12.000 call (FOLD241018C00012000) Follow 0.6500 0.0000 (0.00%) At close: April 25 at 9:46 AM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for FOLD241018C00012000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: FOLD When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable? Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report 13 Best Biotech Stocks To Buy Under $20 Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD) Amicus Therapeutics Stock Sees RS Rating Improve To 74 Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? Amicus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024 Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates Q4 2023 Amicus Therapeutics Inc Earnings Call
